Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes

通过调节晚期反应基因使 Rett 综合征中的 E:I 失衡正常化

基本信息

  • 批准号:
    10076486
  • 负责人:
  • 金额:
    $ 8.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-04 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY AND CAREER DEVELOPMENT ABSTRACT Rett syndrome (RTT) is a devastating neurodevelopmental disorder for which there are currently no viable treatment strategies. The majority of RTT cases result from loss of function mutations in a transcription factor known as methyl CpG binding protein 2 (MECP2), and knockout of Mecp2 (Mecp2-KO) results in RTT- like phenotypes and pathologies in rodents. The brains of RTT-model mice are characterized by acquired microcephaly, which results not from neural atrophy, but rather a reduction in synapses and the subsequent simplification of the neuronal arbor. As such, the preclinical treatment strategies that have garnered the most attention are those designed to normalize synaptic density, often through the replacement of late response (LR) or direct modulation of their receptors. In this capacity RTT-mouse models are valuable tools to guide therapeutic design; however, given the challenges associated with translating data from mice to humans, we have recently adopted a different strategy. Using cortical and cerebellar tissue from 8 RTT patients, we performed RNA-sequencing (seq) analysis to screen for novel points of intervention that are rooted in human patient data, and then back-modeled relevant hits in mice. Excitingly, we identified the muscarinic acetylcholine receptor 4 (M4) as a gene significantly decreased in RTT patients. This finding is salient, as M4-modulators have been shown to rescue symptom domains in diseases like schizophrenia that overlap with RTT and M4- KO mice have cognitive and social deficits similar to Mecp2-KO mice. This raises the exciting possibility that attenuated M4 expression and signaling could be underlying cognitive and social phenotypes in RTT patients. In Aim 1, we propose to further develop preliminary data indicating that cognitive and social phenotypes in Mecp2-KO mice are responsive to M4 positive allosteric modulators (PAMs). In Aim 2, we propose to conclusively link M4-signaling to RTT in patients by perform an RNA-seq analysis on autopsy samples from patients that have been clinically diagnosed with RTT, but who do not have mutations in MECP2 (MECP2- mutation negative). Finally, in Aim 3 we propose co-administer our M4-PAM with modulators of glutamatergic and GABAergic signaling, to establish whether a complimentary symptom domains can be rescued. My career goal is to become the head of a lab with a research focus on pediatric diseases of the nervous system, and I have identified four areas of insufficient training that I propose to remedy to assist in achieving long term success in that role. The four areas are: 1) Training in electrophysiology 2) Training next generation sequencing analysis 3) Clinical exposure to RTT and 4) Mentor experience. To remove these technical and conceptual barriers, I have developed a training plan that integrates formal didactic training with hands-on mentorship, with the goal of turning these weaknesses into strengths. It is anticipated that completion of the proposed project and training plan will place me in an ideal position to receive a tenure track faculty position, and as such, I believe that this application is well suited for a K01 Career Development Award.
项目总结和职业发展摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rocco George Gogliotti其他文献

Rocco George Gogliotti的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Rocco George Gogliotti', 18)}}的其他基金

miRNA site-blocking ASOs as MeCP2 targeted therapeutics
miRNA 位点阻断 ASO 作为 MeCP2 靶向治疗
  • 批准号:
    10648126
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
A precision medicine approach to Rett Syndrome
雷特综合症的精准医学方法
  • 批准号:
    10155598
  • 财政年份:
    2020
  • 资助金额:
    $ 8.23万
  • 项目类别:
A precision medicine approach to Rett Syndrome
雷特综合症的精准医学方法
  • 批准号:
    10613600
  • 财政年份:
    2020
  • 资助金额:
    $ 8.23万
  • 项目类别:
A precision medicine approach to Rett Syndrome
雷特综合症的精准医学方法
  • 批准号:
    10392413
  • 财政年份:
    2020
  • 资助金额:
    $ 8.23万
  • 项目类别:
Normalizing E:I imbalance in Rett Syndrome by Modulation of Late Response Genes
通过调节晚期反应基因使 Rett 综合征中的 E:I 失衡正常化
  • 批准号:
    9449084
  • 财政年份:
    2017
  • 资助金额:
    $ 8.23万
  • 项目类别:

相似国自然基金

糖尿病ED中成纤维细胞衰老调控内皮细胞线粒体稳态失衡的机制研究
  • 批准号:
    82371634
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
胆固醇合成蛋白CYP51介导线粒体通透性转换诱发Th17/Treg细胞稳态失衡在舍格伦综合征中的作用机制研究
  • 批准号:
    82370976
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
自噬流/炎症小体失衡在新生儿缺血缺氧性脑病中的作用机制
  • 批准号:
    82372205
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目
乳杆菌代谢物PolyP通过LuxS/AI-2途径调控菌斑生物膜介导的矿化失衡机制研究
  • 批准号:
    82370941
  • 批准年份:
    2023
  • 资助金额:
    48.00 万元
  • 项目类别:
    面上项目
衰老上皮细胞FABP4调控HSDL2致脂肪酸代谢失衡在BPH发病中的机制研究
  • 批准号:
    82370774
  • 批准年份:
    2023
  • 资助金额:
    49.00 万元
  • 项目类别:
    面上项目

相似海外基金

The impact of effort-reward imbalance on newcomer mental health: A longitudinal investigation
努力与回报失衡对新人心理健康的影响:纵向调查
  • 批准号:
    24K16418
  • 财政年份:
    2024
  • 资助金额:
    $ 8.23万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Imbalance between cell biomass production and envelope biosynthesis underpins the bactericidal activity of cell wall -targeting antibiotics
细胞生物量产生和包膜生物合成之间的不平衡是细胞壁靶向抗生素杀菌活性的基础
  • 批准号:
    2884862
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
    Studentship
AGS-FIRP Track 2: Understanding Vertical Variation of Energy Dissipation near the Surface for Solving the Mystery of the Observed Surface Energy Imbalance
AGS-FIRP 轨道 2:了解地表附近能量耗散的垂直变化,以解决观测到的地表能量不平衡之谜
  • 批准号:
    2231229
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
    Standard Grant
Accurate and Individualized Prediction of Excitation-Inhibition Imbalance in Alzheimer's Disease using Data-driven Neural Model
使用数据驱动的神经模型准确、个性化地预测阿尔茨海默病的兴奋抑制失衡
  • 批准号:
    10727356
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
Genetic regulation of genes on active and inactive X chromosome and their contribution to sex-biased diseases
活性和非活性 X 染色体上基因的遗传调控及其对性别偏见疾病的贡献
  • 批准号:
    10751331
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
Neurotoxicity of Spermine Synthase-deficiency and Polyamine Imbalance
精胺合酶缺乏和多胺失衡的神经毒性
  • 批准号:
    10752966
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
The intersection of diet, cell metabolic state, and SIV reservoir transcription
饮食、细胞代谢状态和 SIV 储存库转录的交叉点
  • 批准号:
    10618546
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
Integrative analysis of whole genomes and transcriptomes from multiple cell types in rare disease patients
罕见病患者多种细胞类型的全基因组和转录组的综合分析
  • 批准号:
    10587683
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
The Interplay of Host Genetic Variation and the Gut Microbiome in Crohn's Disease
克罗恩病宿主遗传变异与肠道微生物组的相互作用
  • 批准号:
    10751276
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
Non-Contact Sleep Stage Estimation: Machine Learning in Multi-Imbalance Data for Improvements in Accuracy and Interpretability
非接触式睡眠阶段估计:多重不平衡数据中的机器学习,以提高准确性和可解释性
  • 批准号:
    22KJ1367
  • 财政年份:
    2023
  • 资助金额:
    $ 8.23万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了